Associate Professor of Biomedical Engineering and Herbert and Florence Irving Associate Professor of Cancer Data Research
Elham Azizi’s multidisciplinary research utilizes novel machine learning, artificial intelligence (AI), statistical modeling, and cutting-edge single-cell and spatial genomics to decode how tumors evolve, resist therapies, and evade the immune system.
By integrating information across genomic, spatial, and imaging modalities, the Azizi Lab reconstructs the rules governing tumor ecosystems directly from patient data. The group designs AI and statistical methods that integrate multi-modal single-cell, spatial, imaging, and perturbation data to identify mechanisms of cellular plasticity, predict immunotherapy responses, and guide experimentally testable hypotheses for improving patient outcomes. These computational models provide interpretable, mechanistically grounded insights into how cancer, immune, and stromal cells communicate and adapt, informing the design of more precise and durable therapies.
Azizi holds a BSc in Electrical Engineering from Sharif University of Technology (2008), and an MSc in Electrical Engineering (2010) and PhD in Bioinformatics (2014) from Boston University. She was a postdoctoral fellow at Columbia University and Memorial Sloan Kettering Cancer Center (2014–2019) before joining the faculty of Columbia Biomedical Engineering and the Irving Institute for Cancer Dynamics in 2020. She is also affiliated with the Department of Computer Science, Data Science Institute, and the Herbert Irving Comprehensive Cancer Center. She is also affiliated with the Department of Computer Science, Data Science Institute, and the Herbert Irving Comprehensive Cancer Center. She is a recipient of the Vilcek Prize for Creative Promise in Biomedical Science, Takeda/NYAS Early-Career Innovator in Science Award, Allen Distinguished Investigator Award, Chan Zuckerberg Initiative SDL Award, NSF CAREER Award, Tri-Institutional Breakout Prize for Junior Investigators, NIH NCI Pathway to Independence Award, American Cancer Society Postdoctoral Fellowship, and IBM Best Paper Award at the New England Statistics Symposium.